Monday, April 29, 2024
HomeTagsVon Willebrand factor

von Willebrand factor

Vega Therapeutics Receives FDA Orphan Drug Designation for VGA039 for the Treatment of von Willebrand Disease

Vega Therapeutics, Inc., a clinical stage biotechnology company developing novel therapies for rare blood disorders, announced that the U.S. Food and Drug Administration (FDA)...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics